From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

In this powerful and hopeful episode of In Two Minds, Professor Caleb Webber explains how vast new datasets and AI-driven pattern-spotting are transforming our understanding of conditions like Parkinson’s and Alzheimer’s.

Caleb is the Director of Informatics at the UK Dementia Research Institute and a leading voice in decoding the complexities of neurodegenerative disease. He reveals groundbreaking findings from his team’s work: surprising overlaps between Parkinson’s and diabetes, the discovery that existing hypertension medications may halve the risk of developing Parkinson’s, and a major new study exploring whether combining blood-pressure drugs with GLP-1 therapies (like Ozempic-type medications) could slow or even prevent the disease.

Caleb offers real reasons for optimism: that prevention may be within reach, that repurposed medications could help people sooner than expected, and that the next decade of brain-health research looks more promising than any before.

This is an episode filled with science, humanity, and genuine hope — for people living with Parkinson’s today, for those caring for them, and for anyone navigating life touched by neurodegenerative disease.

We'd love to hear your stories and your advice for anyone living with dementia - or if you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.

For further help and advice please visit
https://www.alzheimers.org.uk

まだレビューはありません